Study participants
A total of 272 patients were enrolled and randomly assigned to receive aspirin plus sarpogrelate (n = 134, sarpogrelate group) or aspirin plus clopidogrel (n = 137, clopidogrel group) after successful endovascular therapy (EVT) for target FP lesion (Fig. 